OWC Pharmaceutical Research Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Ziv Turner
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 4.6yrs |
CEO ownership | n/a |
Management average tenure | 6.7yrs |
Board average tenure | 6.3yrs |
Recent management updates
Recent updates
CEO
Ziv Turner (52 yo)
4.6yrs
Tenure
Mr. Ziv Turner serves as Founder, Director & VP of BizDev of Cannibble Food-Tech Ltd. He has been Chief Executive Officer at OWC Pharmaceutical Research Corp. since June 21, 2020 and served as its Director...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chief Operating Officer | 10.5yrs | US$94.00k | no data | |
Chief Medical & Regulatory Affairs Officer | 6.9yrs | US$112.00k | no data | |
Chief Executive Officer | 4.6yrs | no data | no data | |
CFO & Secretary | 4.5yrs | no data | no data | |
Chief Scientific Officer | 6.9yrs | no data | no data | |
Consultant | 6.4yrs | no data | no data |
6.7yrs
Average Tenure
58yo
Average Age
Experienced Management: OWCP's management team is seasoned and experienced (6.7 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Member of Advisory Board | 4.6yrs | no data | no data | |
Member of Scientific Advisory Board | 8yrs | no data | no data | |
Senior Advisor to the Scientific Advisory Board | 7.9yrs | no data | no data | |
Member of Advisory Board | 4.6yrs | no data | no data |
6.3yrs
Average Tenure
Experienced Board: OWCP's board of directors are considered experienced (6.3 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/11 11:43 |
End of Day Share Price | 2025/01/07 00:00 |
Earnings | 2019/09/30 |
Annual Earnings | 2018/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
OWC Pharmaceutical Research Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|